Gestione dell’ansia, stress post-traumatico e dei disordini ossessivo-compulsivi/feed/NCT05947461

Search Results

[Articles] Intravascular lithotripsy for the treatment of calcified coronary lesions in individuals of advanced age: a post-hoc analysis of the multicentre, prospective BENELUX-IVL study

In patients of advanced age, IVL for calcified coronary lesions demonstrates a favorable safety and efficacy profile, with high technical success and low rates of device-related adverse events. Nonetheless, larger studies with extended follow-up are warranted to confirm these findings and establish…
Read More Read More: [Articles] Intravascular lithotripsy for the treatment of calcified coronary lesions in individuals of advanced age: a post-hoc analysis of the multicentre, prospective BENELUX-IVL study Data di pubblicazione: Luglio 2025

Post- Dobbs Changes in OBGYN Clinical Workforce

This case-control study compares the availability of women’s health care clinicians in states that enacted highly restrictive abortion policy after the Dobbs Supreme Court decision vs states that established abortion legislation before the Dobbs decision.
Read More Read More: Post- Dobbs Changes in OBGYN Clinical Workforce Data di pubblicazione: Maggio 2025

[Articles] Development and validation of a novel prognostic model to predict 1-year post-transplant mortality for acute-on-chronic hepatitis B liver failure: a nationwide, multicentre, cohort study

The HALT model showed superior predictive ability over eight current models and may help for LT candidate selection and optimal organ allocation. Though the findings need to be verified in prospective studies and among different patient populations.
Read More Read More: [Articles] Development and validation of a novel prognostic model to predict 1-year post-transplant mortality for acute-on-chronic hepatitis B liver failure: a nationwide, multicentre, cohort study Data di pubblicazione: Luglio 2025

Purastat post-EMR: unresolved questions from the PURPLE trial

We read with interest the recently published PURPLE trial evaluating the prophylactic use of Purastat to prevent delayed bleeding following EMR of large duodenal and colorectal lesions.1 While we acknowledge the importance of randomised trials in shaping clinical practice, several methodological co…
Read More Read More: Purastat post-EMR: unresolved questions from the PURPLE trial Data di pubblicazione: Luglio 2025

[Articles] Treatment effects of Xuebijing injection in patients with sepsis by clinical phenotype: a post hoc analysis of the EXIT-SEP trial

We replicated four sepsis phenotypes in the EXIT-SEP cohort, with patterns similar to previously established phenotypes. XBJ treatment was associated with lower 28-day mortality in patients with phenotypes γ and δ, but these findings require further validation.
Read More Read More: [Articles] Treatment effects of Xuebijing injection in patients with sepsis by clinical phenotype: a post hoc analysis of the EXIT-SEP trial Data di pubblicazione: Luglio 2025

Epilessie nei bambini e negli adolescenti

Epilessia

Epilessia

L’epilessia è una grave condizione neurologica che colpisce circa i bambini sotto i 18 anni con molte nuove diagnosi ogni anno. Si...
Read More Read More: Epilessie nei bambini e negli adolescenti

ACC: linee guida su obesità e scompenso cardiaco

Endocrinologia e Malattie Metaboliche

Endocrinologia e Malattie Metaboliche, Obesità e Sovrappeso

Nuove linee guida ACC per il trattamento dell’obesità evidenziano strategie individualizzate e terapie emergenti. Farmaci approvati per...
Read More Read More: ACC: linee guida su obesità e scompenso cardiaco

Alzheimer e Ictus: Scoperta la proteina killer dei neuroni

Notizie dalla Ricerca

Notizie dalla Ricerca

I ricercatori della Johns Hopkins University School of Medicine, Baltimore dicono di aver individuato la proteina responsabile della morte...
Read More Read More: Alzheimer e Ictus: Scoperta la proteina killer dei neuroni

Un farmaco per il diabete potrebbe curare l’Alzheimer.

Notizie dalla Ricerca

Notizie dalla Ricerca

Un farmaco comunemente usato nel trattamento del diabete può invertire i sintomi della malattia di Alzheimer in fase avanzata. Ad...
Read More Read More: Un farmaco per il diabete potrebbe curare l’Alzheimer.

GI highlights from the literature

Basic scienceSensing pain in the gut: new insights into enterochromaffin cells Touhara K, Rossen N, Deng F et al Topological segregation of stress sensors along the gut crypt-villus axis. Nature 2025; 640(8059): 732-742. doi: 10.1038/s41586-024-08581-9. The gut barrier is monitored by enterochromaf…
Read More Read More: GI highlights from the literature Data di pubblicazione: Giugno 2025

PIEZO1 Overexpression in Hereditary Hemorrhagic Telangiectasia Arteriovenous Malformations

Circulation, Ahead of Print. BACKGROUND:Hereditary hemorrhagic telangiectasia is an inherited vascular disorder characterized by arteriovenous malformations (AVMs). Loss-of-function variations in activin receptor-like kinase 1 (ALK1) cause type 2 hereditary hemorrhagic telangiectasia, andAlk1knocko…
Read More Read More: PIEZO1 Overexpression in Hereditary Hemorrhagic Telangiectasia Arteriovenous Malformations Data di pubblicazione: Luglio 2025

L’arma segreta dell’olio d’oliva contro l’Alzheimer: i composti fenolici

Notizie dalla Ricerca

Notizie dalla Ricerca

Una revisione completa sull’International Journal of Molecular Sciences evidenzia il potenziale dell’olio extravergine di oliva e dei...
Read More Read More: L’arma segreta dell’olio d’oliva contro l’Alzheimer: i composti fenolici

Comprensione, prevenzione e trattamento della demenza vascolare

Demenza

Demenza, Neurologia

Uno studio condotto dagli Ospedali universitari di Ginevra (HUG) e dall’Università di Ginevra (UNIGE) getta una luce significativa sulla...
Read More Read More: Comprensione, prevenzione e trattamento della demenza vascolare
Close Search Window
Close